![Open Access](https://i-scholar.in/lib/pkp/templates/images/icons/fulltextgreen.png)
![Restricted Access](https://i-scholar.in/lib/pkp/templates/images/icons/fulltextred.png)
![Open Access](https://i-scholar.in/lib/pkp/templates/images/icons/fulltextgreen.png)
![Open Access](https://i-scholar.in/lib/pkp/templates/images/icons/fulltext_open_medium.gif)
![Restricted Access](https://i-scholar.in/lib/pkp/templates/images/icons/fulltextred.png)
![Restricted Access](https://i-scholar.in/lib/pkp/templates/images/icons/fulltext_restricted_medium.gif)
Evaluation of Plasma Drug Concentration of Vasavaleha
Subscribe/Renew Journal
Plasma concentration of piperine was estimated in vasavaleha treated rats and piperine was detected in plasma from 0.5 to 8 hours after administration with maximum plasma concentration (2.70-1.75 μ/ml) at 0.5-1 hour.
Subscription
Login to verify subscription
User
Font Size
Information
- Bajad S, Bedi K L, Singh A K and Johri R K. Planta Med, 2001, 67; 176.
- EMEA–The European Agency for the Evaluation of Medicinal Products–Evaluation of Medicine for Human Use, London, 2001.
- Guidance for Industry: Bioavailability and bioequivalence studies for orally administered drug products-General considerations, U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2002.
- Sharma G and Mishra B. J Pharmaceutical Research, 2007, 6(3); 129-132.
- Zhixiu L, Hoult J R S, Benett DC and Raman A. Planta Med, 1999, 65: 600.
![](https://i-scholar.in/public/site/images/abstractview.png)
Abstract Views: 429
![](https://i-scholar.in/public/site/images/pdfview.png)
PDF Views: 2